These concerns are being addressed in a current phase 3, double-blind, randomized, placebo-controlled, multicenter study of Voxelotor (ClinicalTrials.gov Identifier: NCT03036813) (Vichinsky et al., 2019)
Klinische Studien und ihre Ergebnisse Erste klinische Studien konzentrieren sich auf das Potenzial von BPC-157 zur Heilung von Verletzungen und zur Verbesserung der Geweberegeneration
No inhibition of influx by the selective GLP-1 receptor antagonist exendin(939), suggesting that the GLP-1 receptor is not involved in the rapid entry into brain
Z., Xie, X., Parik, S., Planque, M., Fendt, S
Schoenenberger collected blood from the cerebral veins of electrically sleep-induced rabbits and isolated a small peptide that, when infused into waking rabbits, appeared to increase slow-wave (delta) EEG activity
Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T, Iijima M, Takekawa H, Usui I, Hiraishi H, Aso Y